Jefferies Says Roche’s Third-Quarter Update Raises Growth Questions
Jefferies analysts say Roche’s underlying sales trends look disappointing and question the drugmaker’s growth trajectory next year.
Jefferies analysts say Roche’s underlying sales trends look disappointing and question the drugmaker’s growth trajectory next year.